Search results
Showing 196 to 210 of 210 results for diagnostic imaging
Evidence-based recommendations on olaparib (Lynparza) for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer in adults.
Early value assessment (EVA) guidance on CaRi-Heart for predicting cardiac risk in suspected coronary artery disease....
Early and locally advanced breast cancer: diagnosis and management (NG101)
This guideline covers diagnosing and managing early and locally advanced breast cancer. It aims to help healthcare professionals offer the right treatments to people, taking into account the person's individual preferences.
Alemtuzumab for treating highly active relapsing–remitting multiple sclerosis (TA312)
Evidence-based recommendations on alemtuzumab (Lemtrada) for treating highly active relapsing–remitting multiple sclerosis in adults.
Biographies and interests register for the indicator advisory committee
Evidence-based recommendations on nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency in adults.
GID-MT563 NPi-200 for pupillary light reflex in critical care patients
Discontinued [GID-MT563]
The MAGEC system for spinal lengthening in children with scoliosis (MT169)
Discontinued [GID-MT544]
GID-MT567 Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain
In development [GID-MT567] Expected publication date: TBC
DHT pilot: DECODE decision support system for the identification of dementia (Discontinued)
Discontinued [GID-MT536]
The IN.PACT drug-coated balloon for peripheral arterial disease (CANCELLED)
Discontinued [GID-MT517]
NICE has today (27 July 2020) published a guideline on the arrangements the NHS should put in place for patients needing elective surgery and other planned treatments and procedures (including diagnostics and imaging) during the COVID-19 pandemic.
Non-invasive MRI scan for Prostate Cancer recommended by NICE
NICE has recommended the scan as a first-line investigation for people with suspected clinically localised prostate cancer.
Thousands of lives in England could be saved each year if the NHS follows updated guidance to help it diagnose cancer earlier. Here we outline what the guidance means for GPs.